USCWA
ALAB icon

U.S. Capital Wealth Advisors’s Astera Labs ALAB Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Buy
+2,282
New +$325K 0.01% 881

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

U.S. Capital Wealth Advisors's ALAB Position: Q1 2026 in Review

U.S. Capital Wealth Advisors opened a new position in Astera Labs (ALAB) in Q1 2026: 2,282 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #881 among its holdings.

709 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • U.S. Capital Wealth Advisors held 2,282 shares of Astera Labs worth $250K as of Q1 2026.
  • Astera Labs was a new U.S. Capital Wealth Advisors position in Q1 2026.
  • Astera Labs made up 0.01% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #881 holding.
  • 709 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.